Quantcast

Talazoparib Plus Irinotecan


#1

The results of Talazoparib plus Irinotecan phase 1 trial will be presented at ASCO 2017:
http://abstracts.asco.org/199/AbstView_199_190793.html
Note that one patient with synovial sarcoma had a partial response. Here is a link to the trial: